Publications

Skip to content

Real-world evidence

New and Noteworthy

The real-world perspective: Why global RWE matters in modern oncology

Real-world evidence
Machine learning
Prostate cancer
Artificial intelligence

The next level in RWE: Flatiron decodes the “why” behind physician decisions for HEOR teams
Answering hematology’s hardest questions: Takeaways from a panel of RWE experts
From data to decisions: What “regulatory-grade” real-world evidence actually requires
- Real-world evidence
- Event recap

All the latest

Topics

Data management

HTA and market access

Health equity

Label expansion

Machine learning

Methodology

Post marketing requirements

Prospective study

Regulatory

Treatment patterns

Trial design

Unmet need

Content type

Article

Case study

Event recap

Podcast

Publications

Video

Webinar

Showing 9 of 0 results

The real-world perspective: Why global RWE matters in modern oncology
High-quality, validated AI-enabled research: Insights from recent prostate cancer research
The next level in RWE: Flatiron decodes the “why” behind physician decisions for HEOR teams
Flatiron Health publishes first peer-reviewed validation framework for AI-extracted real-world oncology data in Journal of Clinical Oncology
Answering hematology’s hardest questions: Takeaways from a panel of RWE experts
How real-world data from over 420,000 patients reveals treatment gaps in prostate and bladder cancer care
From data to decisions: What “regulatory-grade” real-world evidence actually requires
- Real-world evidence
- Event recap
Flatiron launches first-of-its-kind AI-powered global prostate cancer datasets
Webinar: How breakthrough RWE is powering a new era of blood cancer research

Reimagining the infrastructure of cancer care

Resources
Publications
Company
Media
Careers
Contact Us

Real-World Evidence
Point of Care

Legal, Privacy, and Compliance
Cookie Settings
© FLATIRON HEALTH® 2026